EDGAR Filing Documents for 0001193125-09-136768

Form 8-K - Current report:

SEC Accession No. 0001193125-09-136768

Filing Date

2009-06-24

Accepted

2009-06-24 17:25:31

Documents

Period of Report

2009-06-22

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	34690
2	AGREEMENT AND PLAN OF MERGER	dex21.htm	EX-2.1	523376
3	OPTION TERMINATION LETTER	dex101.htm	EX-10.1	6870
4	FORM OF SUPPORT AGREEMENT - DIRECTOR	dex991.htm	EX-99.1	42253
5	FORM OF SUPPORT AGREEMENT - EXECUTIVE OFFICERS	dex992.htm	EX-99.2	39777
6	FORM OF INDEMNITY AGREEMENT	dex993.htm	EX-99.3	43883
	Complete submission text file	0001193125-09-136768.txt		692677

Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080

Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100

Monogram Biosciences, Inc. (Filer) CIK: 0001094961 (see all company filings)